Skip to main content
. 2018 Oct 24;178(2):147–154. doi: 10.1007/s00431-018-3270-3

Table 3.

Secondary outcome measures after 3 and 9 months of intervention: ITT analysis

Outcome variable All (N = 123) HT (N = 45) TM (N = 37) PMR (N = 41) Difference versus baseline (p) Difference between interventions (p)e
Adequate relief (%)
 Baseline
 3 months 39 (32%) 19 (42%) 10 (27%) 10 (24%) 0.16c
 9 months 53 (43%) 24 (53%) 13 (35%) 16 (39%) < 0.001 d 0.21c
RCADS (total) (mean ± SD)
 Baseline 14.5 (8.3) 15.9 (8.5) 12.5 (7.9) 14.7 (8.2) 0.12b
 3 months 13.8 (9.4) 14.9 (10.1) 12.4 (9.6) 13.8 (8.5) 0.53a 0.11b
 9 months 12.4 (9.0) 13.5 (10.0) 11.0 (8.2) 12.3 (8.5) 0.06a 0.16b
RCADS (anxiety) (mean ± SD)
 Baseline 7.6 (4.8) 8.4 (5.0) 6.4 (4.5) 7.6 (4.8) 0.28b
 3 months 7.4 (5.4) 8.0 (5.6) 6.5 (5.4) 7.6 (5.2) 0.80a 0.24b
 9 months 6.5 (5.1) 6.9 (5.5) 5.8 (4.8) 6.8 (5.1) 0.11a 0.31b
RCADS (depression) (mean ± SD)
 Baseline 6.3 (3.6) 6.9 (3.8) 5.5 (3.5) 6.4 (3.6) 0.07b
 3 months 5.8 (3,9) 6.4 (4.5) 5.2 (3.8) 5.7 (3.4) 0.30a 0.16b
 9 months 5.3 (3,8) 6.0 (4.3) 4.8 (3.3) 5.0 (3.4) 0.04 a 0.15b
PCQ (mean ± SD)
 Baseline 99.4 (17.8) 95.5 (14.2) 101.5 (21.1) 101,8 (17.8) 0.19b
 3 months 98.1 (19.9) 97.0 (19.6) 97.3 (21.0) 100.1 (19.6) 0.32a 0.75b
 9 months 97.7 (19.2) 96.4 (20.4) 97.6 (18.8) 99.3 (18.4) 0.27a 0.78b
CSI (mean ± SD)
 Baseline 20.3 (13.7) 22.5 (12.4) 18.4 (15.3) 19.6 (13.5) 0.36b
 3 months 17.3 (13.6) 17.9 (13.0) 17.3 (15.2) 16.7 (12.9) 0.001 a 0.92b
 9 months 15.6 (12.2) 16.0 (12.3) 15.5 (13.2) 15.2 (11.5) < 0.001 a 0.94b

aPaired t test

bOne-sided ANOVA

cChi-squared test

dMcNemar test

ep values were corrected for baseline differences between the groups if these were present

Italicized p-values indicate a statistically significant difference